Chemical context   {#sec1}
==================

Naphtho­quinone derivatives have been studied intensively over the past few decades, mostly because of their numerous biological activities, mainly anti­microbial and anti­tumor (Fujii *et al.*, 1992[@bb4]; Hussain *et al.*, 2007[@bb7]; Epifano *et al.*, 2014[@bb3]). The main mechanism of the activity is related to the formation of reactive oxygen species (ROS) through semiquinonic radicals, which cause damage to cell macromolecules and consequently cell death (Da Silva *et al.*, 2003[@bb1]). Among the substances that comprise this class, some synthetic bioactive derivatives have been obtained from lawsone (2-hy­droxy­naphthalene-1,4-dione) (Jordão *et al.*, 2015[@bb9]). In a basic medium, lawsone shows three sites able to be alkyl­ated (Lamoureux *et al.*, 2008[@bb11]), resulting in *O*-alkyl and *C*-alkyl derivatives difficult to purify in some cases in some cases (Kongkathip *et al.*, 2003[@bb10]). The title compound was obtained in higher yields since oxygen better accommodates the negative charge generated in the enolate formation, using a weak base, propargyl bromide, aprotic solvent and heat. The product has an alkyne terminal chain and can be used as the starting material in the synthesis of triazole derivatives, which are widely exploited in medicinal chemistry (Haider *et al.*, 2014[@bb6]). The present study shows that the title compound has two polymorphs, monoclinic (space group *P*2~1~/*c*) and triclinic (space group *P*ī), crystallized from *N*,*N*-di­methyl­formamide (DMF) and isopropyl alcohol, respectively.

Structural commentary   {#sec2}
=======================

The mol­ecular structures in the two polymorphs are essentially the same (Fig. 1[▸](#fig1){ref-type="fig"}). The naphtho­quinone ring systems in the monoclinic and triclinic forms are both planar, with r.m.s. deviations of 0.015 and 0.029 Å, respectively, for the non-H atoms. Each propargyl group is coplanar with the naphtho­quinone ring system, with C1---C2---O3---C11 and C2---O3---C11---C12 torsion angles being −178.8 (1) and 175.9 (1)°, respectively, for the monoclinic form, and −177.1 (3) and −171.9 (3)°, respectively, for the triclinic form.

Supra­molecular features   {#sec3}
==========================

The mol­ecular arrangements in both crystals are similar (Fig. 2[▸](#fig2){ref-type="fig"}) with nearly the same crystal densities (ρ = 1.383 and 1.392 Mg m^−3^ for the monoclinic and triclinic forms, respect­ively). In the monoclinic crystal, mol­ecules are linked *via* pairs of C---H⋯O hydrogen bonds (C3---H3⋯O2^i^ and C13---H13⋯O1^ii^; symmetry codes as in Table 1[▸](#table1){ref-type="table"}), forming a tape structure running along \[120\]. The tapes are further linked by a C---H⋯π inter­action (C11---H11*A*⋯*Cg*2^iii^; Table 1[▸](#table1){ref-type="table"}) into a layer parallel to the *ab* plane; *Cg*2 is the centroid of the C12≡C13 triple bond \[Fig. 3[▸](#fig3){ref-type="fig"}(*a*)\]. In the layer, mol­ecules are arranged parallel to each other and adjacent layers are linked by another C---H⋯π inter­action (C7---H7⋯*Cg*2^iv^; Table 1[▸](#table1){ref-type="table"}), forming a three-dimensional network \[Fig. 4[▸](#fig4){ref-type="fig"}(*a*)\]. In the tri­clinic crystal, mol­ecules are linked *via* C---H⋯O inter­actions (C3---H3⋯O2^i^, C11---H11*B*⋯O2 ^ii^ and C13---H13⋯O1^iii^; Table 1[▸](#table1){ref-type="table"}) and π--π inter­actions with centroid-centroid distances of 3.9906 (18) and 3.991 (2) Å, respectively, between C1--C4/C10/C9 rings and between C5--C10 rings, forming a layer parallel to the *ab* plane \[Fig. 3[▸](#fig3){ref-type="fig"}(*b*)\]. Adjacent layers are linked by a C---H⋯π inter­action \[Fig. 4([▸](#fig4){ref-type="fig"} *b*); C7---H7⋯*Cg*2^v^; Table 1[▸](#table1){ref-type="table"}\].

Database survey   {#sec4}
=================

A search of the Cambridge Structural Database (Version 5.38; Groom *et al.*, 2016[@bb5]) for naphthalene-1,4-dione gave about 790 structures. Among them, 2-meth­oxy­naphthalene-1,4-dione (Jin *et al.*, 2011[@bb8]) and 2-{\[1-(4-bromo­benz­yl)-1*H*-1,2,3-triazol-4-yl\]meth­oxy}naphthalene-1,4-dione (Raja *et al.*, 2015[@bb12]) are very similar to the title compound. These compounds exhibit additional functional groups linked at O3 and essentially planar naphtho­quinone ring systems and C---H⋯O and π--π inter­actions are also observed in their crystal structures.

Synthesis and crystallization   {#sec5}
===============================

The synthesis of the title compound was achieved in one step according to the literature method (Raja *et al.*, 2015[@bb12]). To a solution of lawsone (0.20 g, 1.15 mmol) in DMF (10 ml) was added K~2~CO~3~ (0.16 g, 1.15 mmol) and propargyl bromide (0.48 g, 4.07 mmol). The mixture was stirred at 363 K for 24 h. Then hydro­chloric acid (1.0 mol l^−1^, 0.34 ml) was added and the resulting solution was extracted with di­chloro­methane (3 × 25 ml). The organic layers were washed with water (60 ml), dried over anhydrous sodium sulfate and concentrated. The solid obtained was purified by column chromatography using silica gel and hexa­ne--ethyl acetate (9:1) and furnished the title compound in 70% yield. Yellow single crystals of the monoclinic and triclinic forms (m.p. 420.0--423.1 K) suitable for X-ray diffraction were obtained by slow evaporation of DMF and isopropyl alcohol solutions (about 0.5 mg ml-1), respectively, at room temperature.

Spectrometric data. IR ν~max~ (cm^−1^): The spectrum show the characteristic absorption bands of the main functional groups for title compound at IR (ν max/cm^−1^): 3250 (C---H alkyne), 3053 (C---H aromatic), 2130 (C≡C) 1649, 1680 (C=O quinone), 1575--1604 (C---C aromatic), 1016, 1208 and 1245 (C---O).^1^H NMR (400 MHz, CDCl~3~): *δ* ~H~ 8.12 (*dd*, 1H, *J* ~5,6~ 7.1 Hz, *J* ~8,7~ 1.9 Hz, H-5), 8,07 (*dd*, 1H, *J* ~8,7~ 7.0 Hz, *J* ~8,6~ 1.9 Hz, H-8), 7.74 (*td*, 1H, *J* ~6,5~ 7.5 Hz, *J* ~6,7~ 7.5 Hz, *J* ~6,8~ 1.7 Hz, H-6), 7.70 (*td*, 1H, *J* ~7,6~ 7.4 Hz, *J* ~7,8~ 7.4 Hz, *J* ~7,5~ 1.6 Hz, H-7), 6.33 (*s*, 1H, H-3), 4.78 (*d*, 2H, *J* ~11,13~ 2.4 Hz, H-11), 2.63 (*t*, 1H, *J* ~13,11~ 2.4 Hz, H-13). ^13^C NMR (100 MHz, CDCl~3~): *δ* ~C~ 184.6 (C-4), 179.8 (C-1), 158.1 (C-2), 134.3 (C-6), 133.4 (C-7), 131.9 (C-10), 131.1 (C-9), 126.7 (C-5), 126.2 (C-8), 111.6 (C-3), 78.2 (C-13), 75.5 (C-12), 56.7 (C-11).

Refinement   {#sec6}
============

Crystal data, data collection and structure refinement details are summarized in Table 2[▸](#table2){ref-type="table"}. C-bound H atoms were constrained to an ideal geometry with C---H = 0.93--0.97 Å and with *U* ~iso~(H) = 1.2*U* ~eq~ (C).

Supplementary Material
======================

Crystal structure: contains datablock(s) Monoclinic, Triclinic, OPLAU. DOI: [10.1107/S2056989018015438/is5501sup1.cif](https://doi.org/10.1107/S2056989018015438/is5501sup1.cif)

###### 

Click here for additional data file.

Supporting information file. DOI: [10.1107/S2056989018015438/is5501Monoclinicsup2.cml](https://doi.org/10.1107/S2056989018015438/is5501Monoclinicsup2.cml)

CCDC references: [1876486](http://scripts.iucr.org/cgi-bin/cr.cgi?rm=csd&csdid=1876486), [1876485](http://scripts.iucr.org/cgi-bin/cr.cgi?rm=csd&csdid=1876485)

Additional supporting information: [crystallographic information](http://scripts.iucr.org/cgi-bin/sendsupfiles?is5501&file=is5501sup0.html&mime=text/html); [3D view](http://scripts.iucr.org/cgi-bin/sendcif?is5501sup1&Qmime=cif); [checkCIF report](http://scripts.iucr.org/cgi-bin/paper?is5501&checkcif=yes)

2-(Prop-2-yn-1-yloxy)naphthalene-1,4-dione (Monoclinic). Crystal data {#d1e141}
=====================================================================

  ------------------------- ---------------------------------------
  C~13~H~8~O~3~             *F*(000) = 440
  *M~r~* = 212.19           *D*~x~ = 1.392 Mg m^−3^
  Monoclinic, *P*2~1~/*c*   Mo *K*α radiation, λ = 0.71073 Å
  *a* = 10.0911 (7) Å       Cell parameters from 1655 reflections
  *b* = 4.8021 (3) Å        θ = 3.9--30.6°
  *c* = 20.8939 (15) Å      µ = 0.10 mm^−1^
  β = 91.174 (7)°           *T* = 293 K
  *V* = 1012.27 (12) Å^3^   Rod, yellow
  *Z* = 4                   0.35 × 0.2 × 0.1 mm
  ------------------------- ---------------------------------------

2-(Prop-2-yn-1-yloxy)naphthalene-1,4-dione (Monoclinic). Data collection {#d1e264}
========================================================================

  --------------------------------------------------------------------------- --------------------------------------
  Rigaku Xcalibur Atlas Gemini ultra diffractometer                           3452 independent reflections
  Radiation source: fine-focus sealed X-ray tube, Enhance (Mo) X-ray Source   1765 reflections with *I* \> 2σ(*I*)
  Graphite monochromator                                                      *R*~int~ = 0.058
  Detector resolution: 10.4186 pixels mm^-1^                                  θ~max~ = 32.8°, θ~min~ = 2.8°
  ω scans                                                                     *h* = −13→15
  Absorption correction: multi-scan (CrysAlis PRO; Rigaku OD, 2015)           *k* = −7→7
  *T*~min~ = 0.764, *T*~max~ = 1.000                                          *l* = −30→31
  10652 measured reflections                                                  
  --------------------------------------------------------------------------- --------------------------------------

2-(Prop-2-yn-1-yloxy)naphthalene-1,4-dione (Monoclinic). Refinement {#d1e381}
===================================================================

  ------------------------------------- -------------------------------------------------------------------------------------
  Refinement on *F*^2^                  Primary atom site location: dual
  Least-squares matrix: full            Hydrogen site location: inferred from neighbouring sites
  *R*\[*F*^2^ \> 2σ(*F*^2^)\] = 0.059   H-atom parameters constrained
  *wR*(*F*^2^) = 0.156                  *w* = 1/\[σ^2^(*F*~o~^2^) + (0.0571*P*)^2^\] where *P* = (*F*~o~^2^ + 2*F*~c~^2^)/3
  *S* = 1.00                            (Δ/σ)~max~ \< 0.001
  3452 reflections                      Δρ~max~ = 0.19 e Å^−3^
  145 parameters                        Δρ~min~ = −0.20 e Å^−3^
  0 restraints                          
  ------------------------------------- -------------------------------------------------------------------------------------

2-(Prop-2-yn-1-yloxy)naphthalene-1,4-dione (Monoclinic). Special details {#d1e533}
========================================================================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

2-(Prop-2-yn-1-yloxy)naphthalene-1,4-dione (Monoclinic). Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å^2^) {#d1e552}
===========================================================================================================================================================

  ------ -------------- ------------- ------------- -------------------- --
         *x*            *y*           *z*           *U*~iso~\*/*U*~eq~   
  O1     0.08336 (12)   0.4803 (2)    0.34723 (5)   0.0512 (3)           
  O2     0.50658 (13)   1.0905 (3)    0.41264 (6)   0.0646 (4)           
  O3     0.19024 (11)   0.3978 (2)    0.46005 (5)   0.0493 (3)           
  C1     0.17768 (15)   0.6268 (3)    0.36127 (7)   0.0381 (4)           
  C2     0.24795 (16)   0.5949 (3)    0.42459 (7)   0.0390 (4)           
  C3     0.35379 (16)   0.7492 (3)    0.44063 (7)   0.0434 (4)           
  H3     0.3937         0.7248        0.4807        0.052\*              
  C4     0.40849 (16)   0.9546 (3)    0.39706 (8)   0.0419 (4)           
  C5     0.38922 (16)   1.1922 (3)    0.29135 (8)   0.0445 (4)           
  H5     0.4645         1.2953        0.3021        0.053\*              
  C6     0.32525 (17)   1.2340 (4)    0.23311 (8)   0.0495 (4)           
  H6     0.3576         1.3651        0.2046        0.059\*              
  C7     0.21324 (18)   1.0817 (4)    0.21695 (8)   0.0528 (5)           
  H7     0.1701         1.1116        0.1778        0.063\*              
  C8     0.16518 (16)   0.8854 (4)    0.25877 (8)   0.0460 (4)           
  H8     0.0899         0.7832        0.2477        0.055\*              
  C9     0.22882 (15)   0.8402 (3)    0.31716 (7)   0.0362 (3)           
  C10    0.34126 (15)   0.9961 (3)    0.33397 (7)   0.0363 (4)           
  C11    0.24569 (19)   0.3468 (3)    0.52323 (7)   0.0488 (4)           
  H11A   0.2477         0.5175        0.5480        0.059\*              
  H11B   0.3354         0.2761        0.5204        0.059\*              
  C12    0.16027 (19)   0.1408 (4)    0.55324 (8)   0.0510 (5)           
  C13    0.0907 (2)     −0.0220 (4)   0.57682 (9)   0.0649 (6)           
  H13    0.0352         −0.1518       0.5956        0.078\*              
  ------ -------------- ------------- ------------- -------------------- --

2-(Prop-2-yn-1-yloxy)naphthalene-1,4-dione (Monoclinic). Atomic displacement parameters (Å^2^) {#d1e882}
==============================================================================================

  ----- ------------- ------------- ------------- -------------- ------------- -------------
        *U*^11^       *U*^22^       *U*^33^       *U*^12^        *U*^13^       *U*^23^
  O1    0.0476 (7)    0.0589 (7)    0.0465 (7)    −0.0115 (6)    −0.0106 (5)   0.0087 (5)
  O2    0.0593 (8)    0.0758 (9)    0.0578 (9)    −0.0230 (7)    −0.0195 (6)   0.0080 (7)
  O3    0.0576 (8)    0.0521 (7)    0.0377 (6)    −0.0075 (6)    −0.0101 (5)   0.0117 (5)
  C1    0.0386 (8)    0.0394 (8)    0.0362 (8)    0.0037 (7)     −0.0047 (6)   −0.0009 (7)
  C2    0.0474 (9)    0.0381 (8)    0.0315 (8)    0.0030 (7)     −0.0020 (7)   0.0039 (6)
  C3    0.0494 (9)    0.0474 (9)    0.0330 (8)    0.0008 (8)     −0.0112 (7)   0.0019 (7)
  C4    0.0415 (9)    0.0438 (9)    0.0402 (9)    0.0014 (7)     −0.0068 (7)   −0.0023 (7)
  C5    0.0397 (8)    0.0453 (9)    0.0485 (10)   −0.0006 (7)    0.0016 (7)    0.0030 (8)
  C6    0.0524 (10)   0.0523 (10)   0.0439 (10)   0.0008 (8)     0.0037 (8)    0.0122 (8)
  C7    0.0571 (11)   0.0630 (11)   0.0380 (9)    0.0015 (9)     −0.0095 (8)   0.0115 (8)
  C8    0.0453 (9)    0.0519 (10)   0.0405 (9)    −0.0034 (8)    −0.0086 (7)   0.0065 (7)
  C9    0.0367 (8)    0.0374 (8)    0.0343 (8)    0.0040 (7)     −0.0028 (6)   0.0017 (6)
  C10   0.0361 (8)    0.0369 (8)    0.0356 (8)    0.0060 (6)     −0.0025 (6)   −0.0011 (6)
  C11   0.0655 (11)   0.0482 (10)   0.0323 (8)    −0.0007 (9)    −0.0078 (7)   0.0043 (7)
  C12   0.0674 (12)   0.0489 (10)   0.0366 (9)    0.0023 (9)     −0.0013 (8)   0.0006 (8)
  C13   0.0780 (15)   0.0633 (12)   0.0536 (12)   −0.0049 (11)   0.0071 (10)   0.0095 (10)
  ----- ------------- ------------- ------------- -------------- ------------- -------------

2-(Prop-2-yn-1-yloxy)naphthalene-1,4-dione (Monoclinic). Geometric parameters (Å, º) {#d1e1215}
====================================================================================

  --------------------- ------------- -------------------- -------------
  O1---C1               1.2145 (18)   C8---C7              1.380 (2)
  O2---C4               1.2241 (18)   C8---H8              0.9300
  O3---C2               1.3423 (18)   C9---C10             1.398 (2)
  O3---C11              1.4442 (19)   C9---C1              1.478 (2)
  C1---C2               1.496 (2)     C9---C8              1.384 (2)
  C2---C3               1.337 (2)     C10---C4             1.483 (2)
  C3---H3               0.9300        C10---C5             1.390 (2)
  C4---C3               1.458 (2)     C11---C12            1.462 (3)
  C5---C6               1.380 (2)     C11---H11A           0.9700
  C5---H5               0.9300        C11---H11B           0.9700
  C6---C7               1.382 (2)     C12---C13            1.167 (2)
  C6---H6               0.9300        C13---H13            0.9300
  C7---H7               0.9300                             
                                                           
  O1---C1---C9          122.19 (14)   C6---C5---H5         120.0
  O1---C1---C2          120.61 (14)   C6---C7---H7         119.9
  O2---C4---C10         121.15 (15)   C7---C8---C9         120.16 (16)
  O2---C4---C3          120.59 (15)   C7---C6---H6         119.9
  O3---C2---C1          110.92 (14)   C7---C8---H8         119.9
  O3---C11---H11A       110.4         C8---C9---C10        119.80 (14)
  O3---C11---H11B       110.4         C8---C9---C1         119.77 (14)
  O3---C11---C12        106.62 (14)   C8---C7---C6         120.20 (16)
  C2---O3---C11         117.37 (13)   C8---C7---H7         119.9
  C2---C3---C4          121.94 (14)   C9---C10---C4        120.35 (14)
  C2---C3---H3          119.0         C9---C1---C2         117.20 (14)
  C3---C2---O3          127.29 (15)   C9---C8---H8         119.9
  C3---C2---C1          121.78 (14)   C10---C9---C1        120.42 (14)
  C3---C4---C10         118.26 (14)   C10---C5---H5        120.0
  C4---C3---H3          119.0         H11A---C11---H11B    108.6
  C5---C6---H6          119.9         C12---C11---H11A     110.4
  C5---C6---C7          120.24 (15)   C12---C11---H11B     110.4
  C5---C10---C9         119.55 (14)   C12---C13---H13      180.0
  C5---C10---C4         120.10 (15)   C13---C12---C11      179.1 (2)
  C6---C5---C10         120.05 (16)                        
                                                           
  O1---C1---C2---O3     −1.5 (2)      C8---C9---C1---C2    −177.9 (1)
  O1---C1---C2---C3     178.5 (1)     C9---C1---C2---O3    179.1 (1)
  O2---C4---C3---C2     −179.0 (2)    C9---C10---C4---O2   −179.6 (2)
  O3---C2---C3---C4     178.9 (1)     C9---C10---C5---C6   0.6 (2)
  C1---C9---C8---C7     −179.2 (2)    C9---C8---C7---C6    0.1 (3)
  C1---C9---C10---C5    178.8 (1)     C9---C1---C2---C3    −1.0 (2)
  C1---C9---C10---C4    −1.7 (2)      C9---C10---C4---C3   −0.3 (2)
  C1---C2---C3---C4     −1.0 (2)      C10---C9---C1---O1   −177.1 (1)
  C2---O3---C11---C12   175.9 (1)     C10---C5---C6---C7   0.1 (3)
  C5---C10---C4---O2    −0.1 (2)      C10---C9---C8---C7   0.7 (2)
  C5---C6---C7---C8     −0.5 (3)      C10---C9---C1---C2   2.3 (2)
  C8---C9---C1---O1     2.7 (2)       C10---C4---C3---C2   1.7 (2)
  C8---C9---C10---C5    −1.0 (2)      C11---O3---C2---C3   1.2 (2)
  C8---C9---C10---C4    178.5 (1)     C11---O3---C2---C1   −178.8 (1)
  --------------------- ------------- -------------------- -------------

2-(Prop-2-yn-1-yloxy)naphthalene-1,4-dione (Triclinic). Crystal data {#d1e1706}
====================================================================

  ------------------------ --------------------------------------
  C~13~H~8~O~3~            *Z* = 2
  *M~r~* = 212.19          *F*(000) = 220
  Triclinic, *P*1          *D*~x~ = 1.383 Mg m^−3^
  *a* = 3.9906 (6) Å       Mo *K*α radiation, λ = 0.71073 Å
  *b* = 11.6943 (16) Å     Cell parameters from 796 reflections
  *c* = 12.3413 (16) Å     θ = 3.2--22.3°
  α = 63.347 (14)°         µ = 0.10 mm^−1^
  β = 83.343 (12)°         *T* = 293 K
  γ = 83.018 (12)°         Rod, yellow
  *V* = 509.69 (14) Å^3^   0.35 × 0.2 × 0.1 mm
  ------------------------ --------------------------------------

2-(Prop-2-yn-1-yloxy)naphthalene-1,4-dione (Triclinic). Data collection {#d1e1834}
=======================================================================

  --------------------------------------------------------------------------- -------------------------------------
  Rigaku Xcalibur Atlas Gemini ultra diffractometer                           2503 independent reflections
  Radiation source: fine-focus sealed X-ray tube, Enhance (Mo) X-ray Source   923 reflections with *I* \> 2σ(*I*)
  Graphite monochromator                                                      *R*~int~ = 0.084
  Detector resolution: 10.4186 pixels mm^-1^                                  θ~max~ = 29.5°, θ~min~ = 3.2°
  ω scans                                                                     *h* = −5→5
  Absorption correction: multi-scan (CrysAlis PRO; Rigaku OD, 2015)           *k* = −14→15
  *T*~min~ = 0.773, *T*~max~ = 1.000                                          *l* = −16→16
  7730 measured reflections                                                   
  --------------------------------------------------------------------------- -------------------------------------

2-(Prop-2-yn-1-yloxy)naphthalene-1,4-dione (Triclinic). Refinement {#d1e1951}
==================================================================

  ------------------------------------- -------------------------------------------------------------------------------------
  Refinement on *F*^2^                  Primary atom site location: dual
  Least-squares matrix: full            Hydrogen site location: inferred from neighbouring sites
  *R*\[*F*^2^ \> 2σ(*F*^2^)\] = 0.064   H-atom parameters constrained
  *wR*(*F*^2^) = 0.184                  *w* = 1/\[σ^2^(*F*~o~^2^) + (0.0469*P*)^2^\] where *P* = (*F*~o~^2^ + 2*F*~c~^2^)/3
  *S* = 1.00                            (Δ/σ)~max~ \< 0.001
  2503 reflections                      Δρ~max~ = 0.24 e Å^−3^
  145 parameters                        Δρ~min~ = −0.23 e Å^−3^
  0 restraints                          
  ------------------------------------- -------------------------------------------------------------------------------------

2-(Prop-2-yn-1-yloxy)naphthalene-1,4-dione (Triclinic). Special details {#d1e2103}
=======================================================================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

2-(Prop-2-yn-1-yloxy)naphthalene-1,4-dione (Triclinic). Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å^2^) {#d1e2122}
==========================================================================================================================================================

  ------ ------------ -------------- -------------- -------------------- --
         *x*          *y*            *z*            *U*~iso~\*/*U*~eq~   
  O1     0.1734 (6)   0.9294 (2)     0.1987 (2)     0.0641 (7)           
  O2     0.9527 (6)   0.4894 (2)     0.3422 (2)     0.0669 (8)           
  O3     0.3732 (5)   0.82577 (18)   0.41940 (19)   0.0502 (6)           
  C1     0.3597 (7)   0.8310 (3)     0.2279 (3)     0.0434 (8)           
  C2     0.4859 (7)   0.7629 (3)     0.3529 (3)     0.0403 (8)           
  C3     0.6822 (7)   0.6529 (3)     0.3868 (3)     0.0446 (8)           
  H3     0.7612       0.6142         0.4642         0.053\*              
  C4     0.7756 (7)   0.5920 (3)     0.3068 (3)     0.0469 (8)           
  C5     0.7466 (8)   0.6005 (3)     0.1040 (3)     0.0623 (10)          
  H5     0.8690       0.5209         0.1307         0.075\*              
  C6     0.6507 (9)   0.6636 (4)     −0.0147 (4)    0.0734 (12)          
  H6     0.7105       0.6264         −0.0676        0.088\*              
  C7     0.4685 (9)   0.7804 (4)     −0.0543 (3)    0.0693 (11)          
  H7     0.4083       0.8226         −0.1343        0.083\*              
  C8     0.3734 (8)   0.8360 (3)     0.0234 (3)     0.0544 (9)           
  H8     0.2467       0.9147         −0.0038        0.065\*              
  C9     0.4678 (7)   0.7737 (3)     0.1427 (3)     0.0428 (8)           
  C10    0.6598 (7)   0.6563 (3)     0.1823 (3)     0.0447 (8)           
  C11    0.4891 (8)   0.7741 (3)     0.5405 (3)     0.0532 (9)           
  H11A   0.7294       0.7831         0.5362         0.064\*              
  H11B   0.4510       0.6837         0.5849         0.064\*              
  C12    0.2992 (8)   0.8455 (3)     0.6013 (3)     0.0518 (9)           
  C13    0.1377 (9)   0.9034 (3)     0.6476 (3)     0.0692 (11)          
  H13    0.0087       0.9496         0.6846         0.083\*              
  ------ ------------ -------------- -------------- -------------------- --

2-(Prop-2-yn-1-yloxy)naphthalene-1,4-dione (Triclinic). Atomic displacement parameters (Å^2^) {#d1e2458}
=============================================================================================

  ----- ------------- ------------- ------------- -------------- -------------- --------------
        *U*^11^       *U*^22^       *U*^33^       *U*^12^        *U*^13^        *U*^23^
  O1    0.0807 (17)   0.0553 (14)   0.0518 (16)   0.0214 (13)    −0.0130 (12)   −0.0243 (12)
  O2    0.0784 (17)   0.0510 (14)   0.0670 (17)   0.0249 (13)    −0.0154 (13)   −0.0273 (12)
  O3    0.0621 (14)   0.0495 (13)   0.0460 (14)   0.0123 (10)    −0.0128 (11)   −0.0294 (11)
  C1    0.0431 (18)   0.0423 (18)   0.044 (2)     0.0002 (14)    0.0003 (15)    −0.0204 (16)
  C2    0.0425 (18)   0.0415 (18)   0.040 (2)     0.0020 (14)    −0.0068 (14)   −0.0206 (16)
  C3    0.0479 (19)   0.0440 (18)   0.0411 (19)   0.0029 (15)    −0.0038 (14)   −0.0195 (15)
  C4    0.0456 (19)   0.0450 (19)   0.048 (2)     −0.0002 (15)   −0.0002 (15)   −0.0204 (16)
  C5    0.068 (2)     0.068 (2)     0.064 (3)     0.0107 (19)    −0.0070 (19)   −0.044 (2)
  C6    0.077 (3)     0.095 (3)     0.069 (3)     0.009 (2)      −0.008 (2)     −0.057 (3)
  C7    0.073 (3)     0.089 (3)     0.052 (2)     0.003 (2)      −0.0072 (19)   −0.038 (2)
  C8    0.059 (2)     0.055 (2)     0.043 (2)     0.0090 (17)    −0.0107 (17)   −0.0171 (18)
  C9    0.0392 (18)   0.0492 (19)   0.045 (2)     −0.0027 (14)   0.0019 (15)    −0.0268 (16)
  C10   0.0482 (19)   0.0462 (19)   0.043 (2)     0.0013 (15)    −0.0035 (15)   −0.0238 (16)
  C11   0.051 (2)     0.066 (2)     0.050 (2)     0.0075 (17)    −0.0159 (17)   −0.0329 (19)
  C12   0.056 (2)     0.058 (2)     0.046 (2)     0.0043 (17)    −0.0090 (17)   −0.0274 (18)
  C13   0.078 (3)     0.079 (3)     0.054 (2)     0.018 (2)      −0.0136 (19)   −0.036 (2)
  ----- ------------- ------------- ------------- -------------- -------------- --------------

2-(Prop-2-yn-1-yloxy)naphthalene-1,4-dione (Triclinic). Geometric parameters (Å, º) {#d1e2809}
===================================================================================

  --------------------- ------------ -------------------- ------------
  O1---C1               1.220 (3)    C7---H7              0.9300
  O2---C4               1.236 (3)    C8---C7              1.378 (4)
  O3---C2               1.339 (3)    C8---H8              0.9300
  O3---C11              1.447 (3)    C9---C8              1.394 (4)
  C1---C2               1.499 (4)    C10---C9             1.393 (4)
  C1---C9               1.481 (4)    C10---C4             1.478 (4)
  C2---C3               1.339 (3)    C10---C5             1.382 (4)
  C3---H3               0.9300       C11---H11A           0.9700
  C4---C3               1.449 (4)    C11---H11B           0.9700
  C5---H5               0.9300       C12---C11            1.454 (4)
  C5---C6               1.389 (5)    C12---C13            1.164 (4)
  C6---H6               0.9300       C13---H13            0.9300
  C6---C7               1.369 (4)                         
                                                          
  O1---C1---C2          120.7 (3)    C6---C5---H5         120.1
  O1---C1---C9          121.8 (3)    C7---C8---C9         119.7 (3)
  O3---C2---C1          111.2 (2)    C7---C8---H8         120.1
  O3---C11---C12        107.6 (2)    C7---C6---C5         120.2 (3)
  O3---C11---H11A       110.2        C7---C6---H6         119.9
  O3---C11---H11B       110.2        C8---C7---H7         119.7
  O2---C4---C10         121.0 (3)    C8---C9---C1         120.2 (3)
  O2---C4---C3          120.2 (3)    C9---C8---H8         120.1
  C2---C3---C4          122.2 (3)    C9---C10---C4        120.3 (3)
  C2---O3---C11         117.2 (2)    C9---C1---C2         117.5 (3)
  C2---C3---H3          118.9        C10---C9---C1        120.1 (3)
  C3---C2---O3          127.8 (3)    C10---C9---C8        119.7 (3)
  C3---C2---C1          121.0 (3)    C10---C5---H5        120.1
  C3---C4---C10         118.7 (3)    C10---C5---C6        119.9 (3)
  C4---C3---H3          118.9        H11A---C11---H11B    108.5
  C5---C10---C9         119.8 (3)    C12---C11---H11A     110.2
  C5---C10---C4         119.9 (3)    C12---C11---H11B     110.2
  C5---C6---H6          119.9        C12---C13---H13      180.0
  C6---C7---C8          120.6 (4)    C13---C12---C11      177.6 (3)
  C6---C7---H7          119.7                             
                                                          
  O1---C1---C2---O3     −1.3 (4)     C5---C10---C9---C1   177.0 (3)
  O1---C1---C2---C3     178.0 (3)    C5---C10---C9---C8   −2.0 (5)
  O1---C1---C9---C10    −175.2 (3)   C5---C10---C4---O2   0.8 (5)
  O1---C1---C9---C8     3.8 (5)      C5---C10---C4---C3   179.7 (3)
  O2---C4---C3---C2     −178.8 (3)   C5---C6---C7---C8    −1.0 (6)
  O3---C2---C3---C4     177.5 (3)    C9---C1---C2---O3    179.1 (3)
  C1---C2---C3---C4     −1.7 (5)     C9---C1---C2---C3    −1.5 (5)
  C1---C9---C8---C7     −178.5 (3)   C9---C10---C5---C6   1.9 (5)
  C2---O3---C11---C12   −171.9 (3)   C9---C8---C7---C6    1.0 (6)
  C2---C1---C9---C10    4.4 (5)      C10---C9---C8---C7   0.5 (5)
  C2---C1---C9---C8     −176.6 (3)   C10---C4---C3---C2   2.3 (5)
  C4---C10---C9---C1    −3.9 (5)     C10---C5---C6---C7   −0.5 (6)
  C4---C10---C9---C8    177.1 (3)    C11---O3---C2---C1   −177.1 (3)
  C4---C10---C5---C6    −177.1 (3)   C11---O3---C2---C3   3.7 (5)
  --------------------- ------------ -------------------- ------------

![(*a*) The mol­ecular structure of the title compound (monoclinic form) with the atom labelling. Displacement ellipsoids of non-H atoms are drawn at the 50% probability level. (*b*) A view of the overlay of the mol­ecular structures of the monoclinic and triclinic forms of the title compound.](e-74-01731-fig1){#fig1}

![Packing diagrams of the title compound, showing the stacked naphtho­quinone mol­ecules: (*a*) monoclinic form viewed along the *b* axis and (*b*) triclinic form viewed along the *a* axis.](e-74-01731-fig2){#fig2}

![Selected inter­molecular inter­actions in the crystals of (*a*) the monoclinic form and (*b*) the triclinic form. Purple dashed lines represent the C---H⋯O hydrogen bonds and green dashed lines the C---H⋯π and π--π inter­actions. *Cg*1 is the centroid of the C5--C10 ring, while *Cg*2 is the midpoint of the C12≡C13 bond.](e-74-01731-fig3){#fig3}

![Partial packing diagrams of (*a*) the monoclinic form and (*b*) the triclinic from. Purple dashed lines represent the C---H⋯O hydrogen bonds and green dashed lines the C---H⋯π and π--π inter­actions.](e-74-01731-fig4){#fig4}

###### Hydrogen-bond geometry (Å, °).

*Cg*2 is the midpoint of the C12≡C13 bond.

  *D*---H⋯A                 *D*---H   H⋯*A*   *D*⋯*A*     *D*---H⋯*A*
  ------------------------- --------- ------- ----------- -------------
  **Monoclinic form**                                      
  C3---H3⋯O2^i^             0.93      2.58    3.436 (2)   153
  C13---H13⋯O1^ii^          0.93      2.33    3.350 (2)   173
  C11---H11*A*⋯*Cg*2^iii^   0.97      2.91    3.740 (4)   145
  C7---H7⋯*Cg*2^iv^         0.93      2.87    3.703 (4)   151
                                                           
  **Triclinic form**                                       
  C3---H3⋯O2^i^             0.93      2.49    3.409 (4)   173
  C11---H11*B*⋯O2^ii^       0.97      2.52    3.380 (4)   149
  C13---H13⋯O1^iii^         0.93      2.44    3.340 (5)   164
  C7---H7⋯*Cg*2^v^          0.93      2.93    3.829 (4)   162

Symmetry codes: monoclinic: (i) −1 − *x*, 2 − *y*, 1 − *z*; (ii) −*x*, −*y*, 1 − *z*; (iii) *x*, −1 + *y*, *z*; (iv) *x*,  − *y*, − + *z*. Triclinic: (i) 2 − *x*, 1 − *y*, 1 − *z*; (ii) 1 − *x*, 1 − *y*, 1 − *z*; (iii) −*x*, 2 − *y*, 1 − *z*; (iv) −*x*, 2 − *y*, −*z*; (v) *x*, *y*, −1 + *z*.

###### Experimental details

                                                                             Monoclinic                                            Triclinic
  -------------------------------------------------------------------------- ----------------------------------------------------- -----------------------------------------------------
  Crystal data                                                                                                                     
  Chemical formula                                                           C~13~H~8~O~3~                                         C~13~H~8~O~3~
  *M* ~r~                                                                    212.19                                                212.19
  Crystal system, space group                                                Monoclinic, *P*2~1~/*c*                               Triclinic, *P*
  Temperature (K)                                                            293                                                   293
  *a*, *b*, *c* (Å)                                                          10.0911 (7), 4.8021 (3), 20.8939 (15)                 3.9906 (6), 11.6943 (16), 12.3413 (16)
  α, β, γ (°)                                                                90, 91.174 (7), 90                                    63.347 (14), 83.343 (12), 83.018 (12)
  *V* (Å^3^)                                                                 1012.27 (12)                                          509.69 (14)
  *Z*                                                                        4                                                     2
  Radiation type                                                             Mo *K*α                                               Mo *K*α
  μ (mm^−1^)                                                                 0.10                                                  0.10
  Crystal size (mm)                                                          0.35 × 0.2 × 0.1                                      0.35 × 0.2 × 0.1
                                                                                                                                   
  Data collection                                                                                                                  
  Diffractometer                                                             Rigaku Xcalibur Atlas Gemini ultra                    Rigaku Xcalibur Atlas Gemini ultra
  Absorption correction                                                      Multi-scan (*CrysAlis PRO*; Rigaku OD, 2015[@bb13])   Multi-scan (*CrysAlis PRO*; Rigaku OD, 2015[@bb13])
  *T* ~min~, *T* ~max~                                                       0.764, 1.000                                          0.773, 1.000
  No. of measured, independent and observed \[*I* \> 2σ(*I*)\] reflections   10652, 3452, 1765                                     7730, 2503, 923
  *R* ~int~                                                                  0.058                                                 0.084
                                                                                                                                   
  Refinement                                                                                                                       
  *R*\[*F* ^2^ \> 2σ(*F* ^2^)\], *wR*(*F* ^2^), *S*                          0.059, 0.156, 1.01                                    0.064, 0.184, 1.00
  No. of reflections                                                         3452                                                  2503
  No. of parameters                                                          145                                                   145
  H-atom treatment                                                           H-atom parameters constrained                         H-atom parameters constrained
  Δρ~max~, Δρ~min~ (e Å^−3^)                                                 0.19, −0.20                                           0.24, −0.24

Computer programs: *CrysAlis PRO* (Rigaku OD, 2015[@bb13]), *SHELXT* (Sheldrick, 2015*a* [@bb14]), *SHELXL2014* (Sheldrick, 2015*b* [@bb15]) and *OLEX2* (Dolomanov *et al.*, 2009[@bb2]).
